ORCHPHARMAOrchid PharmaORCHPHARMA info
$16.68info0.69%24h
Global rank8627
Market cap$680.62M
Change 7d-11.14%
YTD Performance96.30%
SP500 benchmarkOutperform
P/E1.47
P/S8.57
Revenue$79.39M
Earnings$5.52M
Dividend yield-
Main Sector
Healthcare

Orchid Pharma (ORCHPHARMA) Stock Overview

Orchid Pharma Limited, a pharmaceutical company, engages in the development, manufacture, and marketing of active pharmaceutical ingredients, bulk actives, finished dosage formulations, and nutraceuticals in India. Its active pharmaceutical ingredients product portfolio includes oral cephalosporins, injectable cephalosporins, veterinary products, and non-antibiotics. The company's multi-therapeutic presence in anti-infectives, anti-inflammatory, central nervous system, cardiovascular segment, nutraceuticals, and other oral and sterile products, as well as offers new drug discovery systems and pharmaceutical research and development services. It also exports its products to approximately 40 countries internationally. The company was formerly known as Orchid Chemicals & Pharmaceuticals Limited and changed its name to Orchid Pharma Limited in October 2015. Orchid Pharma Limited was incorporated in 1992 and is headquartered in Chennai, India. Orchid Pharma Limited operates as a subsidiary of Dhanuka Laboratories Limited.

ORCHPHARMA Stock Information

Symbol
ORCHPHARMA
Address
Orchid TowersChennai, 600034India
Founded
-
Trading hours
-
Website
https://www.orchidpharma.com
Country
🇮🇳 India
Phone Number
91 44 2821 1000

Orchid Pharma (ORCHPHARMA) Price Chart

-
Value:-

Orchid Pharma Overview: Key Details and Summary

Stock data
2023
Change
Price
$16.68
N/A
Market Cap
$680.62M
N/A
Shares Outstanding
40.82M
0.00%
Employees
838.00
N/A
Shareholder Equity
6.89B
6.37%
Valuation
2023
Change
P/E Ratio
1.47
N/A
P/S Ratio
8.57
N/A
P/B Ratio
0.10
N/A
Growth
2023
Change
Return on Equity
0.0008
N/A
Earnings
2023
Change
Revenue
$79.39M
N/A
Earnings
$5.52M
N/A
EPS
11.35
N/A
Earnings Yield
0.6807
N/A
Gross Margin
0.4035
N/A
Operating Margin
0.0446
N/A
Net income margin
0.0696
N/A
Financial Strength
2023
Change
Total Assets
$146.07M
N/A
Total Debt
$39.50M
N/A
Cash on Hand
$3.28M
N/A
Debt to Equity
0.0093
8.90%
Cash to Debt
0.0831
361.06%
Current Ratio
$1.35
-18.43%
logo
Facebook Icon
Twitter Icon
Linkedin Icon
© 2024 Topstocks.org